Yoga in the Treatment of Eating Disorders: a Randomized Trial

NCT ID: NCT02191995

Last Updated: 2019-11-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-07-31

Study Completion Date

2015-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Yoga facilitates the treatment of eating disorders by decreasing symptom severity over time.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anorexia Nervosa Bulimia Nervosa

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

body awareness yoga

body awareness yoga session prior to breakfast meal

Group Type EXPERIMENTAL

yoga

Intervention Type BEHAVIORAL

Control Arm

No intervention

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

yoga

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* admitted to the Anna Westin House treatment facility of the Emily Program in MN during timeframe study is being run

Exclusion Criteria

* declines participation in study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Minnesota

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dianne Neumark-Sztainer, PhD MPH RD

Role: PRINCIPAL_INVESTIGATOR

University of Minnesota

Carol Peterson, PhD LP

Role: PRINCIPAL_INVESTIGATOR

University of Minnesota

Scott Crow, MD

Role: PRINCIPAL_INVESTIGATOR

University of Minnesota

Lisa Diers, RD LD RYT

Role: PRINCIPAL_INVESTIGATOR

The Emily Program

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Emily Program

Saint Paul, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1405S51026

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Online Relapse Prevention Study
NCT04862247 COMPLETED NA
Imaginal Exposure II Study: In-Vivo
NCT03934697 COMPLETED NA